Article Text

PDF
Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease
  1. S Otani1,2,
  2. T Sakurai1,
  3. K Yamamoto1,
  4. T Fujita1,
  5. Y Matsuzaki1,
  6. Y Goto1,
  7. Y Ando3,
  8. S Suzuki3,
  9. M Usui2,
  10. M Takeuchi2,
  11. Y Kawakami1
  1. 1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  2. 2Department of Ophthalmology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan
  3. 3Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  1. Correspondence to: Yutaka Kawakami MD, PhD, Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjyukuku, Tokyo, 160-8582, Japan; yutakawa{at}sc.itc.keio.ac.jp

Abstract

Aim: To isolate autoantigens possibly involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.

Methods: Autoantigens recognised by immunoglobulin G antibodies (IgG Ab) in sera from VKH patients were isolated by screening the lambda phage cDNA libraries made from melanocytes and a highly pigmented melanoma cell line with the patients’ sera. Presence of IgG specific for the autoantigens in sera from patients with various panuveitis and healthy individuals was evaluated. Relation between the specific IgG and various clinicopathological features was examined.

Results: KU-MEL-1 was found to be one of the 81 isolated positive clones representing 35 distinct genes, which is a previously isolated melanoma antigen preferentially expressed in melanocytes. The IgG Ab specific for KU-MEL-1 was detected in sera from patients with VKH in significantly higher amounts than in sera from patients with Behçet’s disease, sarcoidosis, and from healthy individuals. Positive serum KU-MEL-1 Ab was significantly associated with HLA-DRB1*0405 and male VKH patients.

Conclusion: KU-MEL-1 was identified as a new autoantigen for VKH. The highly frequent induction of IgG Ab for KU-MEL-1 in HLA-DRB1*0405 positive VKH patients may suggest the possible involvement of KU-MEL-1 specific CD4+ T cells in the pathogenesis of VKH, suggesting the possible use in the development of diagnostic and therapeutic treatments for VKH patients.

  • Ab, antibody
  • CTL, cytotoxic T cells
  • IgG, immunoglobulin G
  • LEDGF, lens epithelium derived growth factor
  • PBMC, peripheral blood mononuclear cells
  • PCR, polynerase chain reaction
  • pfu, plaque forming units
  • SRD, serous retinal detachment
  • UACA, uveal autoantigen with coiled coil domains and ankyrin repeats
  • VKH, Vogt-Koyanagi-Harada
  • Vogt-Koyanagi-Harada disease
  • KU-MEL-1
  • DNA cloning
  • autoimmunity
  • uveitis
  • Ab, antibody
  • CTL, cytotoxic T cells
  • IgG, immunoglobulin G
  • LEDGF, lens epithelium derived growth factor
  • PBMC, peripheral blood mononuclear cells
  • PCR, polynerase chain reaction
  • pfu, plaque forming units
  • SRD, serous retinal detachment
  • UACA, uveal autoantigen with coiled coil domains and ankyrin repeats
  • VKH, Vogt-Koyanagi-Harada
  • Vogt-Koyanagi-Harada disease
  • KU-MEL-1
  • DNA cloning
  • autoimmunity
  • uveitis

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.